Annuncio • Jun 30
Huabao Technology Co., Ltd. to Report First Half, 2026 Results on Aug 27, 2026 Huabao Technology Co., Ltd. announced that they will report first half, 2026 results on Aug 27, 2026 Board Change • May 20
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 2 highly experienced directors. 4 independent directors (5 non-independent directors). VP & Non-Independent Director Pengliang Han was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Annuncio • Mar 31
Huabao Flavours & Fragrances Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Huabao Flavours & Fragrances Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Annuncio • Mar 20
Huabao Flavours & Fragrances Co., Ltd., Annual General Meeting, Apr 10, 2026 Huabao Flavours & Fragrances Co., Ltd., Annual General Meeting, Apr 10, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shanghai China Annuncio • Dec 31
Huabao Flavours & Fragrances Co., Ltd. to Report Fiscal Year 2025 Results on Mar 21, 2026 Huabao Flavours & Fragrances Co., Ltd. announced that they will report fiscal year 2025 results on Mar 21, 2026 Annuncio • Sep 30
Huabao Flavours & Fragrances Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Huabao Flavours & Fragrances Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Annuncio • Jul 02
Huabao Flavours & Fragrances Co., Ltd. to Report First Half, 2025 Results on Aug 19, 2025 Huabao Flavours & Fragrances Co., Ltd. announced that they will report first half, 2025 results on Aug 19, 2025 Annuncio • Mar 31
Huabao Flavours & Fragrances Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Huabao Flavours & Fragrances Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Annuncio • Mar 29
Huabao Flavours & Fragrances Co., Ltd., Annual General Meeting, Apr 18, 2025 Huabao Flavours & Fragrances Co., Ltd., Annual General Meeting, Apr 18, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shanghai China Annuncio • Dec 31
Huabao Flavours & Fragrances Co., Ltd. to Report Fiscal Year 2024 Results on Mar 29, 2025 Huabao Flavours & Fragrances Co., Ltd. announced that they will report fiscal year 2024 results on Mar 29, 2025 Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.18 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.18 in 3Q 2023). Revenue: CN¥411.6m (up 7.1% from 3Q 2023). Net income: CN¥67.8m (down 38% from 3Q 2023). Profit margin: 17% (down from 28% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥17.14, the stock trades at a trailing P/E ratio of 37.1x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years. Annuncio • Sep 30
Huabao Flavours & Fragrances Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Huabao Flavours & Fragrances Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥16.65, the stock trades at a trailing P/E ratio of 36.9x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years. Annuncio • Sep 25
Huabao Flavours & Fragrances Co., Ltd. Approves Interim Dividend for the Year 2024 Huabao Flavours & Fragrances Co., Ltd. approved at its EGM held on 23 September 2024 the interim cash dividend/10 shares (tax included) of CNY 1.20000000 for the year 2024. Annuncio • Aug 30
Huabao Flavours & Fragrances Co., Ltd. Proposes Profit Distribution for the First Half of 2024 Huabao Flavours & Fragrances Co., Ltd. announced on 29 August 2024 the profit distribution proposal for the first half of 2024 as follows: Cash dividend per 10 shares (tax included): CNY 1.20000000. New Risk • Aug 29
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 19% Last year net profit margin: 32% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 131% Cash payout ratio: 125% Earnings have declined by 23% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (19% net profit margin). Reported Earnings • Aug 29
Second quarter 2024 earnings released: EPS: CN¥0.058 (vs CN¥0.17 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.058 (down from CN¥0.17 in 2Q 2023). Revenue: CN¥329.3m (down 6.2% from 2Q 2023). Net income: CN¥34.6m (down 68% from 2Q 2023). Profit margin: 11% (down from 31% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings. Annuncio • Jun 29
Huabao Flavours & Fragrances Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024 Huabao Flavours & Fragrances Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024 Board Change • May 15
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Pengliang Han was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. New Risk • Apr 25
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. Payout ratio: 105% Cash payout ratio: 116% Dividend yield: 4.5% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 105% Cash payout ratio: 116% Earnings have declined by 20% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Annuncio • Mar 30
Huabao Flavours & Fragrances Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024 Huabao Flavours & Fragrances Co., Ltd. announced that they will report Q1, 2024 results on Apr 25, 2024 New Risk • Mar 28
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risks Dividend is not well covered by earnings (97% payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (26% net profit margin). Annuncio • Mar 27
Huabao Flavours & Fragrances Co., Ltd., Annual General Meeting, Apr 16, 2024 Huabao Flavours & Fragrances Co., Ltd., Annual General Meeting, Apr 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shanghai China Reported Earnings • Mar 27
Full year 2023 earnings released: EPS: CN¥0.62 (vs CN¥1.18 in FY 2022) Full year 2023 results: EPS: CN¥0.62 (down from CN¥1.18 in FY 2022). Revenue: CN¥1.48b (down 22% from FY 2022). Net income: CN¥379.0m (down 48% from FY 2022). Profit margin: 26% (down from 38% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥16.11, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 59% over the past three years. Annuncio • Feb 01
Huabao Flavours & Fragrances Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2023 Huabao Flavours & Fragrances Co., Ltd. provided earnings guidance for the year ended December 31, 2023. For the period, the company expects net profit attributable to company's shareholders of RMB 300,000,000 to RMB 440,000,000, decrease of the current year compared to the previous year: 39.30% to 58.62%. Annuncio • Dec 29
Huabao Flavours & Fragrances Co., Ltd. to Report Fiscal Year 2023 Results on Mar 28, 2024 Huabao Flavours & Fragrances Co., Ltd. announced that they will report fiscal year 2023 results on Mar 28, 2024 Annuncio • Nov 08
Huabao Flavours & Fragrances Co., Ltd. Announces Interim Dividend on A Shares for the Year 2023, Payable on 13 November 2023 Huabao Flavours & Fragrances Co., Ltd. announced interim cash dividend/10 shares (tax included) of CNY 2.00000000 on A shares for the year 2023. Record date is 10 November 2023. Ex-date is 13 November 2023. Payment date is 13 November 2023. Reported Earnings • Oct 29
Third quarter 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.22 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.18 (down from CN¥0.22 in 3Q 2022). Revenue: CN¥384.5m (down 17% from 3Q 2022). Net income: CN¥109.3m (down 19% from 3Q 2022). Profit margin: 28% (in line with 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 29% per year whereas the company’s share price has fallen by 25% per year. Annuncio • Oct 28
Huabao Flavours & Fragrances Co., Ltd. Approves 2023 Interim Profit Distribution Huabao Flavours & Fragrances Co., Ltd. at its 1st Extraordinary General Meeting of 2023 on 26 October 2023, during which the following proposal was/were approved: Cash dividend/10 shares (tax included): CNY 2.00000000. Annuncio • Sep 30
Huabao Flavours & Fragrances Co., Ltd. to Report Q3, 2023 Results on Oct 30, 2023 Huabao Flavours & Fragrances Co., Ltd. announced that they will report Q3, 2023 results on Oct 30, 2023 Annuncio • Sep 02
Huabao Flavours & Fragrances Co., Ltd. Proposes Profit Distribution for the First Half of 2023 Huabao Flavours & Fragrances Co., Ltd. announced on 31 August 2023 the profit distribution proposal for the first half of 2023 as Cash dividend/10 shares (tax included): CNY 2.00000000. Reported Earnings • Aug 31
Second quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.30 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.30 in 2Q 2022). Revenue: CN¥351.2m (down 28% from 2Q 2022). Net income: CN¥109.5m (down 40% from 2Q 2022). Profit margin: 31% (down from 38% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year whereas the company’s share price has fallen by 26% per year. Reported Earnings • May 03
First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.35 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.35 in 1Q 2022). Revenue: CN¥341.8m (down 18% from 1Q 2022). Net income: CN¥102.9m (down 52% from 1Q 2022). Profit margin: 30% (down from 52% in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥29.50, the stock trades at a trailing P/E ratio of 25.1x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 1.7% over the past three years. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Ze Quan was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 29
Third quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.36 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.22 (down from CN¥0.36 in 3Q 2021). Revenue: CN¥464.2m (up 3.9% from 3Q 2021). Net income: CN¥135.5m (down 40% from 3Q 2021). Profit margin: 29% (down from 50% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 10% per year. Reported Earnings • Aug 29
Second quarter 2022 earnings released: EPS: CN¥0.30 (vs CN¥0.42 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.30 (down from CN¥0.42 in 2Q 2021). Revenue: CN¥485.9m (up 8.1% from 2Q 2021). Net income: CN¥182.9m (down 28% from 2Q 2021). Profit margin: 38% (down from 57% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year and the company’s share price has also fallen by 9% per year. Buying Opportunity • Aug 25
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 6.3%. The fair value is estimated to be CN¥29.60, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.0% over the last 3 years. Earnings per share has declined by 6.2%. Buying Opportunity • Aug 04
Now 20% undervalued Over the last 90 days, the stock is up 7.4%. The fair value is estimated to be CN¥29.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.0% over the last 3 years. Earnings per share has declined by 6.2%. Board Change • Jul 31
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Ze Quan was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥26.31, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Negligible returns to shareholders over past three years. Buying Opportunity • Apr 29
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 23%. The fair value is estimated to be CN¥28.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.0% over the last 3 years. Earnings per share has declined by 6.2%. Revenue is forecast to grow by 28% in a year. Earnings is forecast to grow by 42% in the next year. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.35 (vs CN¥0.44 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.35 (down from CN¥0.44 in 1Q 2021). Revenue: CN¥416.4m (down 11% from 1Q 2021). Net income: CN¥216.2m (down 21% from 1Q 2021). Profit margin: 52% (down from 59% in 1Q 2021). Over the next year, revenue is forecast to grow 28%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. Reported Earnings • Mar 29
Full year 2021 earnings released: EPS: CN¥1.63 (vs CN¥1.92 in FY 2020) Full year 2021 results: EPS: CN¥1.63 (down from CN¥1.92 in FY 2020). Revenue: CN¥1.94b (down 7.3% from FY 2020). Net income: CN¥1.00b (down 15% from FY 2020). Profit margin: 52% (down from 56% in FY 2020). The decrease in margin was primarily driven by lower revenue. Over the next year, revenue is forecast to grow 23%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Jan 25
Investor sentiment deteriorated over the past week After last week's 22% share price decline to CN¥35.12, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 36% over the past three years. Valuation Update With 7 Day Price Move • Nov 29
Investor sentiment improved over the past week After last week's 26% share price gain to CN¥70.00, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 31% over the past year. Valuation Update With 7 Day Price Move • Nov 13
Investor sentiment improved over the past week After last week's 24% share price gain to CN¥53.50, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 5.2% over the past year. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.44 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥447.0m (down 12% from 3Q 2020). Net income: CN¥223.8m (down 18% from 3Q 2020). Profit margin: 50% (down from 54% in 3Q 2020). The decrease in margin was driven by lower revenue. Reported Earnings • Aug 22
Second quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.45 in 2Q 2020) The company reported a poor second quarter result with weaker earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥449.6m (down 8.3% from 2Q 2020). Net income: CN¥255.9m (down 7.6% from 2Q 2020). Profit margin: 57% (in line with 2Q 2020). Valuation Update With 7 Day Price Move • Jul 28
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥43.02, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 17% over the past year. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improved over the past week After last week's 24% share price gain to CN¥52.21, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 85% over the past year. Reported Earnings • Apr 29
First quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.44 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥467.1m (up 4.9% from 1Q 2020). Net income: CN¥273.8m (up 1.8% from 1Q 2020). Profit margin: 59% (down from 60% in 1Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Mar 20
Full year 2020 earnings released: EPS CN¥1.92 (vs CN¥2.01 in FY 2019) The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.09b (down 4.2% from FY 2019). Net income: CN¥1.18b (down 4.5% from FY 2019). Profit margin: 56% (in line with FY 2019). Is New 90 Day High Low • Mar 09
New 90-day low: CN¥45.01 The company is down 25% from its price of CN¥59.87 on 09 December 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. Is New 90 Day High Low • Jan 29
New 90-day low: CN¥47.80 The company is down 8.0% from its price of CN¥52.00 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. Is New 90 Day High Low • Jan 14
New 90-day low: CN¥48.41 The company is down 5.0% from its price of CN¥51.13 on 16 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Dec 09
New 90-day high: CN¥62.66 The company is up 33% from its price of CN¥46.94 on 10 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. Is New 90 Day High Low • Nov 20
New 90-day high: CN¥58.95 The company is up 9.0% from its price of CN¥53.99 on 21 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥1.22b, largely unchanged from the prior year. Total revenue was CN¥2.13b over the last 12 months, down 3.1% from the prior year.